Design, synthesis, in silico studies, and antidiabetic activity of several sulfanilamide incorporated 2,3-disubstituted thiazolidin-4-ones-Reference-Cited by-同舟云学术

Design, synthesis, in silico studies, and antidiabetic activity of several sulfanilamide incorporated 2,3-disubstituted thiazolidin-4-ones

Published:2023-06-21 Issue:3 Volume:51 Page:
ISSN:2357-3791
Container-title:Revista Colombiana de Química
language:
Short-container-title:Rev. Colomb. Quim.

Author:

Deshpande Shreenivas^ORCID,Wader Mallikarjun,Malagi Prasad V.,Jalihal Prabhu C.

Abstract

A panel of 2,3-disubstituted thiazolidin-4-ones 4a-n was synthesised from Schiff bases 3a-n derived from sulfanilamide, by reaction with thioglycolic acid. The compounds were characterised by means of IR, NMR, and Mass spectral data. Compounds 4a-n were screened for DPPH scavenging assay and compounds 4e, 4h, 4i, and 4n exhibited moderate activity. Compounds 4e, 4h, and 4i were tested at 200 mg/kg and 4e at 50 mg/kg b.w. orally for antidiabetic activity in fructose induced diabetic rats. They exhibited significant antidiabetic activity compared to the control group. Pioglitazone was used as a standard drug. The tested compounds exhibited better and ignificant serum cholesterol lowering activity when compared with the control and standard groups. They also reduced the triglyceride level after the 21st day; however, it was insignificant when compared to the control group. Compound 4n displayed the highest binding energy when docked with PPAR-γ followed by compounds 4e, 4h, and 4i when compared to pioglitazone. The physicochemical, drug likeness and ADME properties of the title compounds were found to be satisfactory.

Publisher

Universidad Nacional de Colombia

Subject

General Chemistry

Reference38 articles.

1. Louis Sanford Goodman, Alfred Zack Gilman, and L. L. Brunton, Goodman and Gilman’s the pharmacological basis of therapeutics, 13th ed. New York, N.Y.: Mcgraw-Hill, 2018, pp. 865-869.

2. Statista, “Diabetics number top countries 2019 | Statista,” Statista, 2019. https://www.statista.com/statistics/281082/countries-with-highest-number-of-diabetics/ (accessed Mar. 27, 2022).

3. P. Zhang, T. Li, X. Wu, E. C. Nice, C. Huang, and Y. Zhang, “Oxidative stress and diabetes: antioxidative strategies,” Frontiers of Medicine, vol. 14, no. 5, pp. 583-600, Apr. 2020, DOI: https://doi.org/10.1007/s11684-019-0729-1.

4. N. Agrawal, “Synthetic and therapeutic potential of 4-thiazolidinone and its analogs,” Current Chemistry Letters, vol. 10, no. 2, pp. 119-138, 2021, doi: https://doi.org/10.5267/j.ccl.2020.11.002.

5. R. Bhutani, D. P. Pathak, G. Kapoor, A. Husain, and Md. A. Iqbal, “Novel hybrids of benzothiazole-1,3,4-oxadiazole-4-thiazolidinone: Synthesis, in silico ADME study, molecular docking and in vivo anti-diabetic assessment,” Bioorganic Chemistry, vol. 83, pp. 6-19, Mar. 2019, DOI: https://doi.org/10.1016/j.bioorg.2018.10.025.